Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

21. November 2024 08:00 ET | Quelle: Biolojic Design

Biolojic Design Appoints Neal Curran as Chief Business Officer

Biolojic Design announced the appointment of Neal Curran as Chief Business Officer.
19. November 2024 08:00 ET | Quelle: Biolojic Design

Biolojic Design Joins Johnson & Johnson Innovation - JLABS

Biolojic Design expands U.S. presences by becoming a resident company at Johnson & Johnson JLABS DC
03. Juni 2024 11:00 ET | Quelle: Biolojic Design

Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany

Biolojic Design Enters into Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany in oncology and immunology
24. April 2024 07:00 ET | Quelle: Biolojic Design

Biolojic Design Announces that Nektar Therapeutics Has Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases

Nektar Therapeutics Has Exercised Its License Option to Develop Biolojic Design's AI-Designed Antibody Targeting TNFR2 in Immunology
25. Februar 2021 07:00 ET | Quelle: Biolojic Design

Biolojic Design Enters a Research Collaboration and License Option Agreement with Nektar Therapeutics to Develop Computationally Designed Antibodies Against a Novel Target for the Potential Treatment of Autoimmune Disease

TEL AVIV, Israel, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Biolojic Design (“Biolojic”), a biotechnology company that computationally designs functional antibodies, today announced that it has entered into...